Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „which“
Suchtreffer
Begriffe & Kennungen
Azilect · 4.8 · Adjunct Therapy The tabulated list below includes adverse reactions which were reported with a higher incidenc
Eintrag öffnenAzilect · 4.8 · Monotherapy The tabulated list below includes adverse reactions which were reported with a higher incidence in
Eintrag öffnenAzomyr · 4.5 · No clinically relevant interactions were observed in clinical trials with desloratadine tablets in which eryth
Eintrag öffnenAzomyr · 4.5 · No clinically relevant interactions were observed in clinical trials with desloratadine tablets in which eryth
Eintrag öffnenBalversa · 4.8 · Abnormal laboratory findings Abnormal laboratory findings (other than hyperphosphataemia, which is described s
Eintrag öffnenBekemv · 4.8 · In all clinical studies, the most serious adverse reaction was meningococcal sepsis which is a common presenta
Eintrag öffnenBeneFIX · 4.8 · Summary of the safety profile Hypersensitivity or allergic reactions (which may include angioedema, burning an
Eintrag öffnenBenlysta · 4.8 · 10 In the subcutaneous SLE clinical study, which excluded patients with a history of psychiatric disorders, se
Eintrag öffnenBenlysta · 4.8 · 34 In the subcutaneous SLE clinical study, which excluded patients with a history of psychiatric disorders, se
Eintrag öffnenBenlysta · 4.8 · In a 52-week open-label study in which 25 paediatric patients (10 to 17 years of age) with SLE received subcut
Eintrag öffnenBenlysta · 4.8 · In a 52-week open-label study in which 25 paediatric patients (10 to 17 years of age) with SLE received subcut
Eintrag öffnenBenlysta · 4.8 · In a 52-week open-label study in which 25 paediatric patients (10 to 17 years of age) with SLE received subcut
Eintrag öffnenBenlysta · 4.8 · In a 52-week placebo-controlled study in which 53 patients (6 to 17 years of age) with SLE received Benlysta (
Eintrag öffnenBenlysta · 4.8 · In a 52-week placebo-controlled study in which 53 patients (6 to 17 years of age) with SLE received Benlysta (
Eintrag öffnenBenlysta · 4.8 · In a 52-week placebo-controlled study in which 53 patients (6 to 17 years of age) with SLE received Benlysta (
Eintrag öffnenBenlysta · 4.8 · In a randomised, double-blind, 52-week, post-marketing safety SLE study (BEL115467) which assessed mortality a
Eintrag öffnenBenlysta · 4.8 · In a randomised, double-blind, 52-week, post-marketing safety SLE study (BEL115467) which assessed mortality a
Eintrag öffnenBenlysta · 4.8 · In a randomised, double-blind, 52-week, post-marketing safety SLE study (BEL115467) which assessed mortality a
Eintrag öffnenBenlysta · 4.8 · In the subcutaneous SLE clinical study, which excluded patients with a history of psychiatric disorders, serio
Eintrag öffnenBesponsa · 4.8 · In the adult pivotal study (N=164), TLS, which may be life-threatening or fatal, was reported in 4/164 (2%) pa
Eintrag öffnen